DENMARK |CO |DKK
|Public Float||130.38M||P/E Ratio||50.28|
|% Short of Float||-||Dividend (Yield)||18.00 (0.02%)|
|Held by Insiders||35.80%||Ex-Dividend Date||May 10, 2021|
|Held by Institutions||21.52%||IPO Date||-|
|Sep 20||Sep 19||Sep 18|
|Jun 21||Mar 21||Dec 20|
|Sep 17, 2021||kr1092.50||kr1101.50||kr1075.50||kr1075.50||-1.38%||337.61K|
|Sep 16, 2021||kr1093.00||kr1104.50||kr1090.50||kr1090.50||-0.27%||132.08K|
Last quarter (ended on June 30 ,2021) Coloplast generated a net income of kr1.25B, representing a 20.49% decrease compared to the same quarter a year before (ended on June 30 ,2020).
Last fiscal year (ended on September 30 ,2020) Coloplast generated a net income of kr4.20B, representing a 8.37% increase compare to the previous fiscal year (ended on September 30 ,2019).
View More Details on Coloplast's “Financials” Section
For the last quarterly earnings period (ended on June 30, 2021) COLO-B reported kr5.88 EPS for the quarter.
View More Details on Coloplast's 'Earnings' Section
Coloplast trades on the Copenhagen stock market in Denmark under the ticker symbol "COLO-B". Coloplast’s stock symbol can also be displayed as "CPH:COLO-B".
Coloplast (CPH:COLO-B) is owned by 21.52% institutional shareholders and by 35.80% insiders. The rest is owned by the public.
Explore More Details on Coloplast's “Ownership” Section
Coloplast's key executive team includes the following managers:
Coloplast (CPH:COLO-B) is classified under the "Healthcare" sector and under the "Medical Instruments & Supplies" industry.
ESG scores assess the degree to which a company’s enterprise business value is at risk driven by environmental, social, and governance issues. The scores are a measure of risk on an absolute scale of 0-100, with a lower score meaning less risk.
COLO-B’s total ESG score is 9.69. The company’s environmental score is 1.03, social score is 2.18 and governance score is 3.48.
Coloplast (CPH:COLO-B) is involved in the following activities (which decreases its ESG score) : "animalTesting".
Currently the number of employees working for Coloplast is 12,500.
Coloplast (CPH:COLO-B) is headquartered in Denmark.
Coloplast’s mailing address is Holtedam 1-3, Humlebæk, Denmark, 3050.
The company’s phone number is 45 49 11 11 11.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
No spam. Only valuable knowledge.